The Great News – Lifestyle
Home
Sample Page
Author:
Microbiotica
Microbiotica Announces Positive Results from its Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma
May 18, 2026